As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and clinically validated efficacy (phytopharmaceuticals) in accordance with Good Clinical Practice. This commitment was showcase

A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural Medicine (OMAI). Prof. Raymond Tjandrawinata, Director of Business Development and Scientific Affairs at PT Dexa Medica, shared the journey of DLBS in devel

The 2022 Indonesian Nutrition Status Survey (SSGI) reported that the prevalence of stunting in Jember reached 34.9%, the highest in East Java. Pharmacologist Prof. Raymond R. Tjandrawinata provided education at the Education on Stunting Intervention for Midwives program in Jember Regency to accelerate the stunting reduction to 14% by 2024 on Friday, October 27, 2023. Prof. Raymond Tjandrawinata, Executive Director of DLBS PT Dexa Medica, has emphasized the importance of using

The President of the Republic of Indonesia (RI) Mr. Joko Widodo appreciated and encouraged the use of Indonesia Indigenous Modern Medicine (OMAI) in the National Health Insurance (JKN). This was conveyed during a visit to the Dexa Group booth with the theme OMAI Fitofarmaka at the Business Matching Exhibition for Increasing the Use of Domestic Production (P3DN) which took place at Istora Gelora Bung Karno (GBK) Senayan, Wednesday, 15 March 2023. During a visit to the Dexa Gro

The Indonesian Pharmaceutical Companies Association (GP Farmasi) held an interactive dialogue entitled “Safe Medicinal Syrups for Children”. It was revealed that the requirement for safe syrup preparations is in accordance with the provisions of the Food and Drug Administration (BPOM). “BPOM in conducting evaluations, in issuing permits, many standards are used both nationally and internationally. What BPOM is doing is international best practice,” said Plt. Director of BPOM

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2% of Indonesia’s total GDP. Therefore, Dexa Group, as one of the national pharmaceutical companies, takes its

Taking an active role in increasing the competitiveness of the national industry through research and sustainable technological innovation in the pharmaceutical sector, Dexa Laboratories of Biomolecular Sciences (DLBS) received the Rintisan Teknologi Industri 2021 award from the Ministry of Industry of the Republic of Indonesia. The award was handed over by the Minister of Industry of the Republic of Indonesia, Mr. Agus Gumiwang Kartasasmita, to the Commercial Director of PT

The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the theme “Indonesian Health Resilience and Independence” on Thursday, March 25, 2021. Indonesian Vice President KH Ma’ruf Amin stated that until now imports of medicinal raw materials in Indonesia are still high. T

Indonesia Indigenous Modern Medicine (OMAI) has been proven preclinically and clinically for the treatment or therapy of disease. At the 2021 Indonesian Medical Herbal Medicine Association Annual Scientific Meeting (PIT PDHMI), scientists and also health practitioners agreed that OMAI could be used for the treatment of patients. “The doctors they train as doctors of western medicine, conventional medicine, but in some countries they have the authority to prescribe herbal medi

Farid Nila Moeloek (FNM) Society held a webinar entitled “Use of Herbs to Increase Immunity in the COVID-19 Pandemic”. The discussion, which was attended by experts in the health sector, concluded that it was time for Indonesian Original Modern Medicine (OMAI) to be included in the medical education curriculum. “How will this OMAI be used by our society, in this case, we have to fight to include it in the medical education curriculum,” said the Minister of Health for the 2014